MBX Biosciences, Inc. Common Stock MBX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T01:00:24.321Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:26:05.824263996Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T01:00:23.516348+00:00
MBX Biosciences, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 48.71 | 173.6% | 21.0% | |||
| 25Δ | 71.89 | 156.9% | 25.2% | 51.12 | 165.9% | 17.7% |
| 30Δ | 53.62 | 144.0% | 13.9% | |||
| 35Δ | 64.29 | 112.3% | 12.7% | 55.70 | 132.4% | 11.2% |
| 40Δ | 62.77 | 107.8% | 10.8% | 57.26 | 133.3% | 9.9% |
| 45Δ | 61.24 | 103.2% | 8.8% | 58.83 | 134.2% | 8.6% |
| 50Δ | 59.80 | 98.9% | 7.0% | 60.49 | 136.3% | 7.4% |
| 55Δ | 58.73 | 96.0% | 6.0% | 62.47 | 142.3% | 6.6% |
| 60Δ | 57.66 | 93.0% | 5.0% | 64.45 | 148.3% | 5.7% |
| 65Δ | 56.59 | 90.1% | 4.0% | 67.45 | 161.4% | 5.1% |
| 70Δ | 55.52 | 87.2% | 3.0% | 71.21 | 178.3% | 4.5% |
| 75Δ | 77.02 | 203.6% | 3.9% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 48.71
- IV
- 173.6%
- B/E move
- 21.0%
25Δ
- Pseudo strike
- 71.89
- IV
- 156.9%
- B/E move
- 25.2%
- Pseudo strike
- 51.12
- IV
- 165.9%
- B/E move
- 17.7%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 53.62
- IV
- 144.0%
- B/E move
- 13.9%
35Δ
- Pseudo strike
- 64.29
- IV
- 112.3%
- B/E move
- 12.7%
- Pseudo strike
- 55.70
- IV
- 132.4%
- B/E move
- 11.2%
40Δ
- Pseudo strike
- 62.77
- IV
- 107.8%
- B/E move
- 10.8%
- Pseudo strike
- 57.26
- IV
- 133.3%
- B/E move
- 9.9%
45Δ
- Pseudo strike
- 61.24
- IV
- 103.2%
- B/E move
- 8.8%
- Pseudo strike
- 58.83
- IV
- 134.2%
- B/E move
- 8.6%
50Δ
- Pseudo strike
- 59.80
- IV
- 98.9%
- B/E move
- 7.0%
- Pseudo strike
- 60.49
- IV
- 136.3%
- B/E move
- 7.4%
55Δ
- Pseudo strike
- 58.73
- IV
- 96.0%
- B/E move
- 6.0%
- Pseudo strike
- 62.47
- IV
- 142.3%
- B/E move
- 6.6%
60Δ
- Pseudo strike
- 57.66
- IV
- 93.0%
- B/E move
- 5.0%
- Pseudo strike
- 64.45
- IV
- 148.3%
- B/E move
- 5.7%
65Δ
- Pseudo strike
- 56.59
- IV
- 90.1%
- B/E move
- 4.0%
- Pseudo strike
- 67.45
- IV
- 161.4%
- B/E move
- 5.1%
70Δ
- Pseudo strike
- 55.52
- IV
- 87.2%
- B/E move
- 3.0%
- Pseudo strike
- 71.21
- IV
- 178.3%
- B/E move
- 4.5%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 77.02
- IV
- 203.6%
- B/E move
- 3.9%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 105.25% | |
| 104.72% | |
| 103.96% | |
| 104.85% | |
| 107.32% | |
| 109.88% | |
| 108.94% | |
| 106.94% | |
| 108.33% | |
| 110.84% |
Biotechnology
MCRB
Description unavailable
More →MDGL
Description unavailable
More →MDWD
Description unavailable
More →MDXG
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
More →MESO
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.
More →MGNX
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville,…
More →